Advertisement
The Zika virus might not remain in the semen of some infected men as long as previously thought

Zika Does Not Appear to Last in Semen As Long As Thought

0
More research is needed to better inform public health recommendations
Candida antigen is a promising

Candida Antigen Safe, Effective for Treating Common Warts

0
IFN-γ may serve as a good predictor of its therapeutic response
Hospital adoption of procalcitonin testing has had little impact on antibiotic prescribing for chronic obstructive pulmonary disease exacerbations

Procalcitonin Testing Not Impacting Antibiotic Rx for COPD

0
Findings among patients hospitalized for chronic obstructive pulmonary disease exacerbation
As kidney function declines

Higher Odds of Infection With Reduced Kidney Function

0
Study finds excess community-acquired infections incidence in individuals with mild to severe CKD
A typical emergency department sees few cases of sepsis among adolescents

Emergency Departments See Few Cases of Sepsis in Adolescents

0
Every 100 years, each of 12 emergency departments would treat 2.8 fatal sepsis cases
The U.S. Food and Drug Administration has announced a recall of numerous liquid pharmaceutical products because of possible bacterial contamination that could cause severe infections in vulnerable patients.

FDA: Potential Contamination in Some Liquid Pharma Products

0
Concerns over possible bacterial contamination that could cause severe infections in vulnerable patients
Zika virus infection is associated with increased incidence of neurological syndromes

Diverse Spectrum of Neurologic Syndromes Seen With Zika

0
Increase in admissions for Guillain-Barré syndrome, encephalitis compared with before outbreak
Adoption of specialty access standards has not improved access to specialists

Specialist Access No Better With Adoption of Access Standards

0
No notable improvement in timely access to specialty services following implementation of standards
Many studies used to support U.S. Food and Drug Administration approval of high-risk medical device modifications are not controlled; and efficacy of drugs granted accelerated approval is often confirmed three years after approval

Studies Used for FDA Approval of Device Changes Often Low Quality

0
And, efficacy of drugs granted accelerated approval often confirmed only years after approval
Two doses of killed whole-cell oral cholera vaccine are efficacious for protecting against cholera for at least two years after vaccination

Review: Killed Whole-Cell Oral Cholera Vaccine Efficacious

0
Efficacy estimates similar during the two years after vaccination; efficacy reduced in third, fourth year